FIZONAC ORANGE FLAVOUR 600 EFFERVESCENT TABLET contains Acetyl Cysteine which belongs to the group of medicines called Mucolytics. It is used in adults to treat acute airway diseases such as bronchitis (inflammation of mucous membrane in airways), emphysema, mucoviscidosis (cystic fibrosis), and/or bronchiectasis (chronic widening of airway passage).
FIZONAC ORANGE FLAVOUR 600 EFFERVESCENT TABLET is not recommended for use in patients allergic to Acetylcysteine. It is also not recommended for use in patients with bronchial asthma.
Before taking FIZONAC ORANGE FLAVOUR 600 EFFERVESCENT TABLET, inform your doctor if you have stomach ulcers, liver diseases (such as non-alcoholic fatty acid disease), and chronic kidney disease.
FIZONAC ORANGE FLAVOUR 600 EFFERVESCENT TABLET should be used with caution in pregnant and breastfeeding women only if it is clearly necessary. The medicine is not recommended for use in children and adolescents (below 18 years) and advised to be used with caution in elderly patients (aged above 60 years) after consulting your doctor.
The most common side effects of taking FIZONAC ORANGE FLAVOUR 600 EFFERVESCENT TABLET are nausea and vomiting. Consult your doctor if any of these symptoms worsens.
FIZONAC ORANGE FLAVOUR 600 EFFERVESCENT TABLET works by enhancing airway secretions and mucociliary function (a defence mechanism of lungs that promote movement and removal of excess mucus) which causes the mucus (phlegm) to become less sticky resulting in its easy removal through cough thus treating airway diseases in affected individuals.
Take FIZONAC ORANGE FLAVOUR 600 EFFERVESCENT TABLET as advised by your physician. Dissolve the medicine in half a glass of water and drink the solution immediately. Do not crush or chew the medicine. Your doctor will decide the correct dose and duration for you depending upon your age, body weight and disease condition.
Stop taking FIZONAC ORANGE FLAVOUR 600 EFFERVESCENT TABLET and contact your doctor if you experience any of the following side effects:
Nausea and vomiting:
Try to take FIZONAC ORANGE FLAVOUR 600 EFFERVESCENT TABLET with or just after a meal or a snack. Stick to simple meals. Avoid eating rich or spicy food. Avoid drinking coffee, alcohol, or smoking. Consult your doctor if the symptom gets worse.
Headache:
If FIZONAC ORANGE FLAVOUR 600 EFFERVESCENT TABLET causes headache, then take rest and drink plenty of fluids. Try to avoid drinking alcohol. Ask your doctor to recommend a painkiller. Headaches should usually go away after the first week of taking FIZONAC ORANGE FLAVOUR 600 EFFERVESCENT TABLET. If it lasts more than a week or becomes severe, then consult and inform your doctor.
Diarrhea:
Drink plenty of water and stay hydrated. Try to avoid taking any medicine on your own to treat diarrhea. Consult and inform your doctor if the symptom worsens.
FIZONAC ORANGE FLAVOUR 600 EFFERVESCENT TABLET should be used with caution in pregnant women only if it is clearly necessary. Consult your doctor before taking it.
FIZONAC ORANGE FLAVOUR 600 EFFERVESCENT TABLET should be used with caution in breastfeeding women only if it is clearly necessary. Consult your doctor taking it.
FIZONAC ORANGE FLAVOUR 600 EFFERVESCENT TABLET is not likely to affect your abilities to drive or use machines. Consult your doctor before taking it.
FIZONAC ORANGE FLAVOUR 600 EFFERVESCENT TABLET should be used with caution in patients with chronic kidney disease. Consult your doctor before taking the medicine.
FIZONAC ORANGE FLAVOUR 600 EFFERVESCENT TABLET should be used with caution in patients with liver diseases such non-alcoholic fatty acid disease. Consult your doctor before taking the medicine.
FIZONAC ORANGE FLAVOUR 600 EFFERVESCENT TABLET is not recommended for use in patients allergic to acetylcysteine, or any other ingredients of this medicine. Consult your doctor before taking the medicine.
FIZONAC ORANGE FLAVOUR 600 EFFERVESCENT TABLET is not recommended to be use in patients with lung diseases such as bronchial asthma. Consult your doctor before taking the medicine.
Before taking FIZONAC ORANGE FLAVOUR 600 EFFERVESCENT TABLET, inform your doctor if you:
Use in Paediatrics:
FIZONAC ORANGE FLAVOUR 600 EFFERVESCENT TABLET is not recommended for use in children and adolescents (below 18 years). Consult your doctor before administering the medicine to the child.
Use in Geriatrics:
FIZONAC ORANGE FLAVOUR 600 EFFERVESCENT TABLET should be used with caution in elderly patients (aged above 60 years). Consult your doctor before taking the medicine.
A. Drug-Drug Interactions:
Before taking FIZONAC ORANGE FLAVOUR 600 EFFERVESCENT TABLET, inform your doctor, if you are taking any of the following medicine:
Overdosage:
If you or anyone else accidentally takes too much of FIZONAC ORANGE FLAVOUR 600 EFFERVESCENT TABLET, consult your doctor immediately or visit the nearby hospital. Symptoms of overdosage are nausea, vomiting, and diarrhoea.
Drug | : | Acetyl Cysteine |
Pharmacological Category | : | Mucolytics |
Therapeutic Indication | : | Acute airway diseases (such as bronchitis, emphysema mucoviscidosis, and/or bronchiectasis) |
Dosage Forms | : | Capsule, Tablet, Effervescent Tablet, Injection |
Q. What FIZONAC ORANGE FLAVOUR 600 EFFERVESCENT TABLET is used for?
A. FIZONAC ORANGE FLAVOUR 600 EFFERVESCENT TABLET is used in adults as a mucolytic (phlegm loosening medicine) to treat airway diseases such as bronchitis, emphysema, mucoviscidosis (cystic fibrosis), and bronchiectasis.
Q. What happens if you take more FIZONAC ORANGE FLAVOUR 600 EFFERVESCENT TABLET than your required dose?
A. If you or anyone else accidentally takes too much of FIZONAC ORANGE FLAVOUR 600 EFFERVESCENT TABLET, consult your doctor immediately or visit the nearby hospital. Symptoms of overdosage are nausea, vomiting, and diarrhoea.
Q. Is it safe to use FIZONAC ORANGE FLAVOUR 600 EFFERVESCENT TABLET in pregnant and breastfeeding women?
A. FIZONAC ORANGE FLAVOUR 600 EFFERVESCENT TABLET should be used with caution in pregnant women and breastfeeding women only if it is clearly necessary. Consult your doctor before taking the medicine.
Q. How FIZONAC ORANGE FLAVOUR 600 EFFERVESCENT TABLET works?
A. FIZONAC ORANGE FLAVOUR 600 EFFERVESCENT TABLET works by enhancing airway secretions and mucociliary function (a defence mechanism of lungs that promote movement and removal of excess mucus) which causes the mucus (phlegm) to become less sticky resulting in its easy removal through cough thus treating airway diseases in affected individuals.
Q. What is method of taking FIZONAC ORANGE FLAVOUR 600 EFFERVESCENT TABLET?
A. Take FIZONAC ORANGE FLAVOUR 600 EFFERVESCENT TABLET as advised by your physician. Dissolve the medicine in half a glass of water and drink the solution immediately. Do not crush or chew the medicine. Your doctor will decide the correct dose and duration for you depending upon your age, body weight and disease condition.
1. Laurence Brunton. Pulmonary Pharmacology. Goodman and Gillman’s The Pharmacological Basics of Therapeutics. Twelfth Edition. 2011. Page – 1057.
2. Micaely Cristina dos Santos Tenório, Nayara Gomes Graciliano, Fabiana Andréa Moura, Alane Cabral Menezes de Oliveira, Marília Oliveira Fonseca Goulart. N-Acetylcysteine (NAC): Impacts on Human Health. NIH National Library of Medicine. National Center for Biotechnology Information. PMC PubMed Central. June 2021. [Accessed on 22nd August 2022] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234027/
3. Manouchehr Khoshbaten, Akbar Aliasgarzadeh, Koorosh Masnadi, Mohammad K Tarzamani, Sara Farhang, Hosain Babaei, Javad Kiani, Maryam Zaare, Farzad Najafipoor. N-Acetylcysteine Improves Liver Function in Patients with Non-Alcoholic Fatty Liver Disease. NIH National Library of Medicine. National Center for Biotechnology Information. PMC PubMed Central. March 2010. [Accessed on 22nd August 2022] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3270338/
4. Minyuan Ye, Weiyuan Lin,1 Jing Zheng, Shaopeng Lin. N-acetylcysteine for chronic kidney disease: a systematic review and meta-analysis. NIH National Library of Medicine. National Center for Biotechnology Information. PMC PubMed Central. April 2021. [Accessed on 22nd August 2022] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129408/
5. Mark F. McCarty and James J. DiNicolantonio. An increased need for dietary cysteine in support of glutathione synthesis may underlie the increased risk for mortality associated with low protein intake in the elderly. NIH National Library of Medicine. National Center for Biotechnology Information. PMC PubMed Central. October 2015. [Accessed on 22nd August 2022] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129408/
6. Elara Pharmaceuticals Limited. Electronic Medicines Compendium (EMC). [Revised in January 2022] [Accessed on 22nd August 2022] https://www.medicines.org.uk/emc/files/pil.8576.pdf
Written By Dr. K .AZEEM HUSSAIN, B.D.S
Last updated on 12 Jan 2023 | 09:36 PM(IST)
The contents of this website are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Do not disregard professional medical advice or delay in seeking it because of something you have read on this website.